PG
ABT icon

Prostatis Group’s Abbott ABT Stock Holding History

Prostatis Group’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-41,415
Closed -$111K – 113
2023
Q2 		$111K Buy
+41,415
New +$4.41M 0.05% 134
2022
Q4 		– Sell
-8,641
Closed -$836K – 98
2022
Q3 		$836K Buy
+8,641
New +$921K 0.96% 27
2022
Q2 		– Sell
-13,250
Closed -$1.57M – 48
2022
Q1 		$1.57M Buy
13,250
+225
+2% +$27.9K 1.26% 26
2021
Q4 		$1.83M Buy
13,025
+1,516
+13% +$194K 1.12% 28
2021
Q3 		$1.36M Buy
11,509
+851
+8% +$105K 0.81% 35
2021
Q2 		$1.24M Buy
10,658
+1,585
+17% +$185K 0.84% 35
2021
Q1 		$1.09M Buy
+9,073
New +$1.07M 0.85% 28

Other funds holding ABT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Prostatis Group's ABT Position: Q3 2023 in Review

Prostatis Group sold out of Abbott (ABT) in Q3 2023, closing a stake of 41,415 shares — an estimated $111K sold.

Prostatis Group first reported a position in ABT in Q1 2021 and held it in 7 quarters. The position peaked at $1.83M in Q4 2021. 2,681 funds tracked by Wall St. Rank hold ABT as of Q3 2023.

  • Prostatis Group reported no remaining Abbott position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 41,415 Abbott shares in Q3 2023, an estimated $111K.
  • Prostatis Group first reported a position in Abbott in Q1 2021 and held it in 7 quarters.
  • Prostatis Group's Abbott position peaked at $1.83M in Q4 2021.
  • 2,681 funds tracked by Wall St. Rank held Abbott as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.